RNA biology has changed completely in the past decade with the discovery of non-coding RNAs. Unfortunately, obtaining mechanistic information about these RNAs alone or in cellular complexes with proteins has been a major problem. X-ray crystallography of RNA and RNA-protein complexes has suffered from the major problems encountered in preparing and purifying them in large quantity. Here, we review the available techniques and methods in vitro and in vivo used to prepare and purify RNA and RNA-protein complex for crystallographic studies. We also discuss the future directions necessary to explore the vast number of RNA species waiting for their atomic-resolution structure to be determined.
Introduction
Interactions between nucleic acids (DNA or RNA) and proteins are well-known regulators of essential cellular functions. DNAprotein complexes are involved in regulation of chromosomal maintenance, replication, transcriptional regulation, and DNA repair. [1] Initially, RNA-protein interactions were thought to be only directly involved in transcription, translation, RNA metabolism, and telomere maintenance among others. [2] However, the RNA component of ribonucleoprotein (RNP) complexes has been found to play a major role in their function and can participate in catalysis as part of the RNP complex or as the sole contributor (e.g. spliceosome, ribosome, signal recognition particle, riboswitches). [2] [3] [4] On the other hand, RNA-protein interactions have only recently begun to be further elucidated.
One of the first steps towards the molecular and mechanistic understanding of these nucleic acid-protein complexes is to determine their structure. Whereas the number of crystallographic structures of DNA-protein complexes (2785 structures) is larger than RNA-protein complexes (1364 structures), most of RNPs remain to be solved using crystallography. The discrepancy in numbers is due to several problems encountered during the purification and crystallization of RNA and RNP complexes. This review will address the crystallization of RNA and RNP complexes from sample preparation, complex reconstitution, and crystallization both in vitro and in vivo and show the path required to be taken in order to solve the remaining structures.
In Vitro Techniques to Purify RNA for RNP Complexes
In vitro transcription is the most extensively used method employed to prepare milligram quantities of the desired RNA, from a template DNA using RNA polymerase, for crystallographic studies (see methodology in Ref. [5] ). Chemical synthesis of RNA is another in vitro method widely used to generate the desired RNA, which relies on obtaining the desired molecule from a commercial company. [5, 6] Although in vitro transcription is the most common method of RNA production, there are several pitfalls with this method for RNA synthesis. [6] One major concern is the heterogeneity caused by the use of RNA polymerases for transcription. This is because they can include several untemplated nucleotides at the 3 0 end of RNA as well as having the tendency to prematurely terminate, which is undesirable for use in crystallography. [6] [7] [8] Although this may be the case, there are several methods that have been compiled to overcome this issue.
One of the main methods of introducing homogeneity into the RNA sample is the use of cis-or trans-ribozymes on the 5 0 and 3 0 end that will self-cleave after the production of the RNA. [7] [8] [9] [10] Although there is only a limited range of RNAs that can be purified using current methods, there are several ribozymes that cleave either at the 5 0 or 3 0 end and can be used to assist in purification. [7] [8] [9] [10] The widely used ribozymes are hepatitis delta virus (HDV) ribozyme [7, 9, 11] and the hammerhead (HH) ribozyme, which are used on the 5 0 and 3 0 end respectively. [8, 10] Both are commonly used in creating multimilligram amounts of RNA for crystallography as the requirements for cleavage are compatible with most RNA constructs. However, introduction of ribozymes causes great difficulty in the purification of in vitro-transcribed RNA, rendering it quite a lengthy procedure.
Several methods have been developed to obtain homogeneous in vitro-transcribed RNA with the use of both native and denaturing methods of purification. However, along with each method of purification, there are several advantages and disadvantages depending on the length and structure of the RNA being purified (Table 1) . It is also essential that the purification protocol used can efficiently remove any heterogeneity in the sample before the formation of RNPs for crystallography. In fact, the sample must not only be homogeneous in terms of size and sequence, but also in terms of structure. Above all, it also must produce a sufficient yield (milligrams) in order to determine the structure using crystallography.
Denaturing Polyacrylamide Gel Electrophoresis (PAGE)
Denaturing polyacrylamide gel electrophoresis (PAGE) is one of the most commonly used techniques to purify in vitrotranscribed RNA for crystallography. [6, 11] This is often performed after transcription, where the product of the crude transcription reaction is loaded onto a pre-heated polyacrylamide gel in which the percentage of the acrylamide depends on the length of RNA. [12] The desired RNA product is then excised and extracted from the gel before refolding under optimal refolding conditions. [6, 11, 13] Advantages of this procedure include the effective separation of the desired RNA from free oligonucleotides, proteins, DNA template, cleaved ribozymes, and abortive transcripts that may have formed during transcription. [5, 14, 15] This procedure yields milligram amounts of RNA for the efficient crystallization of RNA and RNP complexes such as the yitJ SAM-I (S box) riboswitch (nucleotides (nt) 29-146) of Bacillus subtilis (Fig. 1a) (Protein Data Bank number (PDB): 4KQY). [16] Although this method is often used for RNA purification of both long and short RNAs, there are many disadvantages in using this technique (Table 1) . First, the apparatus has a limited loading capacity, meaning that several gels are required to gain a significant yield for the crystallographic analysis of RNA and RNP complexes. [15, 17] Second, this procedure can only resolve RNA that is 20 to 600 nt with agarose gels being preferable for larger RNA molecules. [14, 15] It is possible to separate RNA to single-nucleotide resolution by using a higher percentage of acrylamide (.10 %) in the gel for RNAs .60 nt. [12] Last, a significant amount of RNA is lost through this purification procedure, decreasing the yield of transcribed RNA. [18] Denaturing High-Performance Liquid Chromatography (HPLC)
In an attempt to find an effective method of RNA purification without the need for the standard laborious PAGE procedure, anion-exchange HPLC [19] and ion-pair reverse-phase HPLC [20] can be used to purify homogeneous RNA that was chemically synthesized.
The anion-exchange HPLC method involves the use of an anion-exchange HPLC column (Dionex NuceloPacÒ PA-100, 22 Â 250 mm) of medium capacity fitted with a column heater that will heat the sample at 80-958C. The sample can elute with high resolution and sharp peaks on the chromatogram owing to the conformational homogeneity of denatured RNA at high temperatures. [19] A further advantage of this approach is the yield, which is ,2-5 mg per injection of sample. Using this method, it is possible to achieve single-nucleotide resolution, while high yield and high resolution can be achieved for RNAs that are ,25 nt. [19] In comparison with the previous HPLC method, ion-pair reverse-phase HPLC requires the column (XBridge C18) to be heated to 508C during RNA purification to resolve RNA molecules #59 nt. [20] Although it allows the purification of longer RNA molecules, owing to the decrease in the temperature of the column, the nucleotide resolution is highly dependent on the gradient used. To gain single-nucleotide resolution, a shallow gradient is required, which increases the time required to run the mixture through the column, whereas a steeper gradient will decrease the resolution of the purification. Alternatively, reverse-phase HPLC can be used without heat-denaturing the RNA to produce RNA suitable for crystallography. This was done by Sheng et al., where they successfully crystallized 4-Seuridine-derivatized RNA (5 0 -rUSe U-CGCG-3 0 ) (PDB: 3HGA) using a 21.2 Â 250-mm Zorbax RX-C8 column. [21] Prep Cell RNA Purification: A Denaturing and Non-Denaturing PAGE Alternative
In order to improve PAGE as a single purification step, researchers such as Cunningham et al. and Huang et al. have used PAGE in conjunction with column chromatography to purify RNA. [15] This method in comparison with the conventional PAGE protocol involves loading the RNA into a polyacrylamide gel that elutes the sample through a dialysis membrane and that is then sorted by passing through a UV detector and separated by fractionation. [15, 20] Using this approach, the eluted RNA can be chromatographically identified. The advantages of this approach include the fact that the gel is reusable and can extract milligram quantities of RNA over several runs. [15] The major advantage of this method can be seen in a paper by Huang et al. last year in which a 59-nt RNA construct that could generate different structures was able to be separated (Table 1) . [20] The use of a native gel allowed the separation of RNA strands that have the same length, but different structures. [20] Chromatographic Methods of Native RNA Purification
Recently, there has been a range of chromatographic protocols for native purification of RNA. They are used as an alternative to PAGE owing to the efficiency and high yield (milligrams) of RNA produced by this method. There are two types of chromatography that have been widely used: size-exclusion chromatography [22, 23] and anion-exchange chromatography. [24] [25] [26] These columns are used in conjunction with fastperformance liquid chromatography equipment to allow the large-scale purification of RNA at a much smaller timescale than PAGE.
Size exclusion chromatography (SEC) was the first nondenaturing chromatographic method developed to purify RNA. This method involves first partially purifying the crude transcription mixture using phenol/ chloroform extraction and then applying the resulting product through SEC to obtain the RNA product [22, 23] (full methodology in Ref. [27] ). There are several advantages to this approach, in particular its ability to successfully remove all the constituents of the transcription reaction in a time-efficient manner, without the need of denaturants. [22] SEC can separate multimeric species of RNA from the desired RNA construct. [22, 28] One disadvantage of SEC is its inability to resolve the closely related species of RNA, in particular RNA with additional . [16] (b) The 2.65-Å -resolution crystal structure of the distal region of stem I of T box RNA (PDB: 4JRC). [29] (c) The 2.85-Å -resolution crystal structure of the second glycine-sensing domain from V. cholerae riboswitch (PBD: 3OWZ). [32] (d) The 3.9-Å -resolution crystal structure of the prokaryotic signal-recognition particle (orange) in complex with the soluble domain of the signal recognition particle (SRP) membrane-bound receptor, FtsY (grey), and its cognate 4.5S RNA (PDB: 2AAX). [79] (e) The 2.5-Å -resolution crystal structure of S. pyogenes Cas9 (grey) in complex with single guide RNA and target DNA (PDB: 4OO8). [80] (f) The 2.8-Å resolution crystal structure of the multisubunit S. cerevisiae exosome-RNA bound complex. Various subunits are coloured either grey, orange or cyan (PDB: 4CMP). [81] nucleotides at the 3 0 end. [27, 28] Therefore, the RNA is required to be flanked with ribozymes, which in turn leads to problems in separating the RNA from the ribozymes, requiring a considerable difference in size to be able to separate them using SEC. [23] Although there are limitations to obtaining suitable samples for crystallography with particular RNA constructs, this method does not require any other purification steps. [28] Milligram quantities of the distal region of stem I of T box RNA transcript were obtained and crystallized (Fig. 1b) by Grigg et al. (PDB: 4JRC). [29] Anion-exchange chromatography has become a favourable technique for RNA purification owing to the quick nature of the protocol (,4 h). The crude RNA lysate can be directly injected into the column without the need for prior purification. [28] Initially, procedures used weak anion-exchange chromatography (diethylaminoethanol (DEAE) Sepharose) for RNA purification. [25, 26] However, RNA purification using stronganion exchange chromatography (Mono Q) has allowed largescale preparation of RNA [24] (full methodology in Ref. [26] ). Although both methods are the same, these procedures differ in terms of the binding affinity to the column that requires high salt conditions for elution in the latter procedure, which may affect RNA folding. [24] Similarly to SEC, anion-exchange chromatography has the ability to separate multimeric and aggregated species of RNAs from the RNA sample. [24, 25] However, this is only possible if their overall charge significantly differs from the desired RNA sample. Also, this method can separate samples that are 30-500 nt long, [24, 25] but any RNA molecules that are .500 nt will likely be contaminated with DNA. [25] Furthermore, this method like most others cannot resolve RNA with heterologous 3 0 ends. [25] Several structures have been determined through X-ray crystallography using this as a primary method of purification, such as the human transfer RNA, tRNA Sec (PDB: 3A3A), [30] which used strong anion-exchange chromatography (Resource Q). Others have used this technique in conjunction with denaturing PAGE as a secondary means of purification to solve structures such as the catalytic domain of B. stearothermophilus RNase P RNA, Bst P7D RNA (PDB: 3DHS), [31] and the second glycine-sensing domain from Vibrio cholerae riboswitch in several different forms (Fig. 1c) (PBD: 3OWZ). [32] Using Affinity Tags to Assist in Native RNA Purification
Since the emergence of native RNA purification techniques, there has been a focus on the development of affinity-tagged RNA molecules that can be in vitro-transcribed and later cleaved from the desired RNA with its corresponding substrate. [33] [34] [35] [36] [37] [38] This technique involves two primary components, which include a sequence that binds into a stationary protein and/or nucleotide sequence and an activatable ribozyme. [33] [34] [35] [36] [37] [38] This method is analogous to well-known affinity-tagged protein purification protocols. Owing to the number of abortive transcripts RNA polymerases make during the process of transcription, the tags are designed on the 3 0 end. This will allow any abortive transcripts to flow through the column and allow the full-length RNA molecules to bind.
Although the majority of tags involve a well-known RNAprotein interaction, there is one affinity tag technique that uses DNA affinity to capture the RNA and subsequent cleavage with a DNAzyme (methodology in Ref. [34] ). One of the key aims of this method is to remove the 3 0 heterogeneity that is created by the RNA polymerases. [33] Also, owing to the introduction of the tag on the 3 0 end, this eliminates any abortive constructs in the mixture. [33] This procedure can allow the preparation of milligrams-worth of RNA and with the removal of the 3 0 heterogeneity, makes this suitable to produce RNA for crystallography. Furthermore, owing to the lack of the conventional ribozyme used in the 3 0 end, the use of DNAzyme makes this procedure quite cost-effective. However, there is a sequencespecific requirement for this procedure, which is the need for a purine at the 3 0 end upstream from the reaction site. [33] Although this is a simple procedure, the long period of several days is a drawback. [34] A commonly used affinity tag combines the glmS ribozyme followed by the MS2 RNA that interact with the MS2-MBP fused protein. [35] This combination of affinity tags significantly improves the purification of RNA through the use of selective buffers and cleavage substrates. [35] This purification scheme can allow a broad range of RNAs to be purified; for example, Batey and Kieft tested RNA molecules of 9, 66, and 94 nt in length and found that these molecules could be easily purified. They also assessed the quality of the RNA produced using this method through recrystallizing the SAM-I riboswitch RNA (PDB: 2GIS).
The ARiBo tag is another commonly used tag, replacing the MS2 affinity approach. The ARiBo tag contains an activatable ribozyme (glmS), which has been modified to be able to integrate the lBoxB RNA into its variable P1 stem [38] (methodology in Ref. [36] ). One of the advantages of using this affinity approach is the fact that the RNA-protein affinity is in the picomolar range. [37] This allows the bound RNA to be washed several times, removing any impurities in the mixture before cleavage. The yield for this method is comparable with gelbased procedures, with the advantage of being more timeefficient. [37] These methods purify RNA using purely native conditions in comparison with PAGE but with the same yield; the resulting product is more likely to contain the correctly folded RNA molecule.
In Vivo RNA Transcription
Along with in vitro methods, in vivo methods for both RNA transcription and subsequent RNP complex formation have greatly advanced in recent years.
There are a growing number of reviews that compile evidence highlighting the importance of RNA secondary and tertiary structure in its biological function. This fact coupled with the known difficulty of refolding RNA, especially long non-coding RNA, into a homogeneous species, [39] suggest the standard method of purifying RNA by denaturing PAGE may not be ideal. As early as 1988, Uhlenbeck questioned the wisdom of denaturing RNA during the purification step, likening it to purifying enzymes via sodium dodecyl sulfate (SDS) gels and expecting them to remain active. [13] The original pitfalls of in vivo transcription of RNA, such as the heterogeneity of products, degradation by RNases, and difficultly purifying RNA from cell extracts, have been overcome by novel methods of purification. These include utilizing a tRNA scaffold to avoid RNase degradation [40, 41] and co-expression of RNA with protein chaperones. [42] Transfer RNA 'Scaffolding' Previously, the only successfully expressed RNAs in vivo were native RNAs, such as tRNAs, or were highly structured and had intrinsic RNase stability. [43] Dardel and Ponchon developed an elegant mechanism to overcome degradation of the product RNA during in vivo transcription in Escherichia coli. Transfer RNA's intrinsic stability and its precise 5 0 and 3 0 end, achieved through processing by intracellular enzymes, make it an excellent scaffold molecule to insert an RNA of interest. They built recombinant vectors capable of expressing homologous RNA 'scaffolds' in vivo that had the natural ability to withstand degradation by intracellular nucleases. In these, they replaced the anti-codon stemloop of the tRNA with an RNA of interest and either a Sephadex or streptavidin-binding region flanking the RNA to allow efficient purification from the cell (Fig. 2a) . [41] One drawback to this approach is the method of removing the desired RNA from the tRNA scaffold. RNase H with a pair of DNA oligonucleotides complementary to the scaffold on either side of the RNA insert has been shown to facilitate cleavage. However, annealing of the DNA oligonucleotides requires heating and cooling of the purified RNA, which is not ideal if native RNA folding is desired. Furthermore, the addition of RNases, for enzymatic cleavage of the tRNA scaffold, to a purified RNA introduces the possibility for non-specific digestion of the RNA. To circumvent the use of RNases, the RNA construct can be flanked with cis-acting hammerhead ribozymes. [44] However, for complete separation of the RNA from the scaffold post cleavage, both these methods require either denaturing PAGE separation or denaturing anion-exchange chromatography. [41, 45] Crystallization of RNA Crystallization of RNAs for X-ray diffraction studies is undoubtedly far more challenging than for their protein counterparts. The RNAs' ability to stably fold into multiple secondary structures, [39] along with their surfaces being dominated by a regular array of negatively charged phosphates lead to a general inability of RNAs to form the multiple regular crystal contacts. This, of course, is not favourable for homologous crystal growth and X-ray diffraction to high resolution (,2 Å ). [46] RNA crystallization follows the established principles of protein crystallization. [47, 48] However, as secondary structure information is often already known for the RNA or has been computationally predicted, there are several sequence variants (helix lengths, loops sequences, nucleotide modifications, 5 0 or 3 0 overhangs) that can be trialled to optimize crystal growth [46] and improve diffraction resolution. If the RNA has been denatured during purification, an annealing step must also be performed before crystallization. [49] The initial crystallization screening process for RNA varies only slightly from proteins. RNA and RNP sparse matrix screens have been developed based on their protein counterparts and Sephadex affinity domain may be inserted to allow rapid purification. [41] (b) In vivo-transcribed tRNA scaffold containing the MS2 binding hairpin is simultaneously produced with overexpressed MS2 coat protein. In vivo pseudo-particle formation internalises the RNA of interest and protects it from nucleosomal degradation. [41] (c) Distinct crystal contacts between tRNA and RNase P. The inserted GAAA tetraloop caps the P12 loop of RNase P (red) and contacts the tetraloop receptor (red) on the tRNA (PDB: 3Q1Q). [14] (d) Designed crystal contacts symmetry-related U1A bound hepatitis delta virus (HDV) ribozyme. The 14-nt U1A binding loop (red) facilitates U1A protein association (PDB: 1DRZ). [63] (e) Crystal contact mediated between Fab bound to L1 RNA ligase (PDB: 3IVK). [73] incomplete factorial screens for both hanging and sitting drop trials. [49] [50] [51] [52] Similarly to proteins, RNA will crystallize from a wide range of solutions including cacodylate buffers, HEPES, Tris-HCl and MES using typical precipitants such as PEG and sodium chloride. More common in nucleic acid crystallization is the use of lithium salts, 2-propanol, and 2-methyl-2,4-pentanediol (MPD) as precipitants. [53] The polyanionic nature of RNA requires the addition of a neutralizing charge in the crystallization solution provided by one of a variety of divalent cations (most commonly a magnesium ion), and/or a polyamine such as spermine or spermidine. [54] Cations of other valency states may be added depending on the nature of the RNA molecules being studied. The hydrolysable nature of RNA has resulted in a relatively 'fixed' pH range, between pH 5 and 8, for crystallization. Although RNA crystallization outside this range is not impossible, the number of successfully solved crystal structures decreases significantly outside this range. Temperature variation has a profound effect on RNA crystallization, more so than that for protein. Initial screening should include room-temperature samples along with 48C and 308C samples. The 160-nucleotide domain of the group 1 intron from Tetrahymena thermophila was the first RNA crystallized at 308C. [49] Sequence Optimization RNA crystals form several types of intermolecular interactions: base-pairing and stacking, minor groove packing, tetraloopminor groove interactions, and pseudo-continuous helices. The most obvious means of introducing variation into an RNA sequence is base mutations at the solvent-exposed surface of the molecule. This may readily be done for small RNAs by varying the length of the 5 0 or 3 0 overhangs. [55] Determining which RNA base may be mutated in an attempt to increase possible crystal contacts may be done by experimental probing with chemical reagents such a Fe-EDTA, [56] DMS or nucleases, [57] and further probing experiments such as selective 2 0 -hydroxyl acylation analyzed by primer extension (SHAPE) and inline probing analysis may be performed. [58, 59] The reactive groups identified by probing indicate solventexposed regions of the RNA capable of forming crystal contacts. Through elimination, probing allows one to gain an appreciation of which RNA bases are involved in secondary and tertiary interactions and must not be targeted for mutations. Although not routinely done, this step does allow targeted optimization of RNA and is particularly helpful to access the overall secondary structure for those that lack an in vitro activity assay and for which post-mutational activity assays cannot be performed.
Replacement of solvent-exposed regions of the RNA with RNA tetraloops, especially the GNRA/G tetraloops (where N is A, G, C or U), [51] is a common strategy, because these motifs provide a compact structure and are known to mediate RNA packing. [60] In addition to the GNRA tetraloops, the GAAA tetraloop-receptor interaction has also been used to facilitate RNA packing and crystallization in multiple structures. [46, 61, 62] Perhaps the most famous example is of the structure of the universal ribozyme RNase P complexed with tRNA. To achieve diffraction-quality crystals, the P12 loop of RNase P was capped with a GAAA tetraloop and the tetraloop receptor was added to the pre-tRNA anticodon stem loop (ASL) (Fig. 2c) . This modification, along with subsequent nucleotide elongations at the ASL and P12 loop allowed diffraction-quality crystals (3.8 Å ) to be obtained. [14] Chaperone Proteins, Antibodies, and Pseudo-Particles
Further to the introduction of foreign loops to assist with crystal packing, RNA protein-binding motifs or antibody-binding sequences may be introduced. Not only will the associated protein or antibody provide a 'rigid' tertiary structure, which will facilitate ordered crystal contacts during crystal growth, but they will also provide a platform for solution of the phase problem through either molecular replacement or multi-wavelength anomalous dispersion (MAD) phasing.
The first, and now most commonly used, chaperone protein for RNA crystallization is the RRM-I domain of the human spliceosomal U1A protein (U1A-RBD). It was used effectively to solve the long-awaited structure of the HDV ribozyme. The alteration of the P4 stem of the HDV ribozyme, with the 22-nt RNA stemloop 'ligand', did not adversely affect the selfcleavage activity of the HDV ribozyme, nor did the binding of U1A-RBD, [63] suggesting RNA tertiary structure was retained. U1A-RBD was an ideal choice for cocrystallization with RNA, first because it binds its cognate RNA with very high affinity (dissociation constant K d of 2 Â 10 À11 M), [64] and second, the high-resolution crystal structure of U1A-RBD bound to SLII RNA showed the protein-RNA interaction is confined to a single 10-nt loop of the RNA, [65] leading to the possibility of as few as 12 nucleotides being required for high-affinity binding to U1A-RBD. [66] This method has been used to solve the crystal structure of the Hairpin ribozyme (Fig. 2d) , [67] Glm ribozymeriboswitch, [68] and the flexizyme [69] among other structures. The use of antibodies is an alternative approach to overcome the inherent instability issues of RNA when performing crystallization trials. Antibody fragments have been used as chaperones, in a similar manner as with membrane proteins. [70] The use of antibodies may also potentially eliminate conformational heterogeneity associated with RNA and, in addition, the large size of the antibody would allow phasing via molecular replacement. [71] To this end, Ye et al. used a phage platform for the display of libraries of synthetic antigen-binding fragments (Fabs) and used the P4-P6 domain from the Tetrahymena group I intron as a 'proof of concept' RNA antigen. The selected Fab demonstrated high binding affinity (K d 51 nM) with the P4-P6 RNA domain and showed specificity at the tertiary level when compared with other RNA. The antibody-RNA complex was successfully crystallized and diffracted to 2.25 Å . [72] Following a similar methodology, the catalytic core of a class 1 RNA ligase ribozyme was crystallized and diffracted to 3.0 Å (Fig. 2e) ; [73] however, they remain the only two RNA structured crystallized in complex with an antibody.
Crystallization of RNA Protein Complexes Complex Reassembly In Vitro
Typically, crystallization of RNA protein complexes is performed using complex reconstituted in vitro from individual components. RNA, most commonly transcribed by T7 polymerase in vitro transcription, or commercially chemically synthesized if short enough, is incubated with various components of the RNP complex (usually expressed and purified from E. coli [74, 75] ), before the reconstituted complex is purified from unbound components via gel filtration or ion-exchange chromatography. Molar RNA : protein ratios of 1 : 0.9 are suggested for initial screening, guided by gel shift assays to ensure complete complex formation. [76] Incubation time and temperature must be optimized, through trial and error, to ensure maximal efficiency of complex reassembly. Special care must be taken during this process to ensure that first, the RNA transcribed is chemically homogeneous (methods described earlier ensure this) and second, that purified protein is free of RNase contamination.
Several RNP complexes have been successfully crystallized in this way. Ataide et al. reconstituted the prokaryotic signal recognition particle (SRP) in complex with the soluble domain of the SRP membrane-bound receptor, FtsY. The prokaryotic SRP consists of a 4.5S RNA bound to the Ffh protein. To reassemble the complex, 4.5S was transcribed by T7 polymerase in vitro, purified by denaturing PAGE, and refolded. [77, 78] Sequential incubations of refolded 4.5S with 2Â molar excess of Ffh and FtsY, followed by complex purification using anionexchange chromatography yielded pure complex, which was successfully crystallized, and diffraction to 3.9 Å obtained (Fig. 1d) . [79] Similarly, the crystal structure of Streptococcus pyogenes Cas9 in complex with single-guide RNA (sgRNA) and its target DNA was recently solved using in vitro reassembly. [80] Cas9 was expressed and purified from E. coli and incubated with the 98-nt in vitro-transcribed sgRNA, purified by 10 % PAGE, along with commercially purchased 23-nt target DNA at a molar ratio of 1 : 1.5 : 2.3. The complex was purified by gel filtration before crystallization (Fig. 1e) . [80] Makino et al. successfully used a well-designed small commercially synthesized RNA to solve the remarkable structure of the 440-kDa S. cerevisiae exosome-RNA-bound complex. [81] The exosome is responsible for 3 0 -5 0 degradation of RNA in eukaryotes and consists of 11 subunits forming a non-specific RNA-binding channel. Following in vitro reconstitution of the subunits (expressed and purified from E. coli [82] ), RNAse protection assays were performed to determine the exact length of solvent-inaccessible RNA bases within the complex. This allowed the design of a synthetic RNA, which consists of a 3 0 overhang that spans the RNA-binding pore, and a 5 0 -CG duplex closed by a tetraloop, which stalls further entry of the RNA into the narrow pocket. Incubation of the complex with RNA, in 2Â molar excess, was sufficient for complex formation and subsequent crystallization, and diffraction to 2.8 Å (Fig. 1f) . [81, 82] 
RNP Complex Reassembly In Vivo
Until recently, crystallization of overexpressed RNP complexes reassembled in vivo has been a prospective concept. Methods for in vivo production of RNA have progressed significantly, based around the use of a stable tRNA scaffold. [41] This work was furthered with the design of an RNA-protein expression system utilizing both single or double plasmid mechanisms. RNA-protein co-expression assays in E. coli were used to validate the system and co-expression of phi2 prohead RNA (pRNA) and its binding partner gp10 were successful in vivo. [42] Furthermore, genomic RNA packaged in the E. coli bacteriophage MS2 is resistant to RNase digestion. The bacteriophage MS2 adopts a simple RNP structure composed of 180 MS2 molecules. Additionally, non-phage recombinant RNAs containing a 19-nt hairpin operator sequence can also induce pseudo-particle formation. [83] Co-expression of both MS2 and transfer-messenger RNA (tmRNA) (a unique 347-nt bifunctional mRNA/tRNA) containing the hairpin operator sequence in E. coli led to the assembly of pseudo-particles that were protected against RNA degradation, when compared with tmRNA in vivo expression alone. Following phenol extraction, tmRNA was purified in a single Superose 6 SEC step, providing the first example of in vivo RNA transcription and purification utilizing pseudo-particle complex assembly for nuclease protection (Fig. 2b) . [42] This approached was extended to RNA-protein complexes without the tRNA scaffold. The authors theorized that any RNAbinding protein co-expressed with its RNA would have the similar shielding effect from nuclease degradation as the MS2 pseudo-particles did. They used the broad RNA-binding Hfq protein and the 227-nt SgrS RNA as a proof of concept. In vivo expression of SrgS was observed only when it was co-expressed with Hfq, suggesting Hfq decreases the sensitivity of SgrS to nucleolysis and confirming in vivo reassembly. [42] Affinity tagging of the RNA-binding protein would allow rapid purification of the in vivo-reconstituted complex and may prove to be a useful method for RNP purification that circumvents in vitro reassembly.
To date, the most well-known high-resolution crystal structure of an RNP complex purified from in vivo is the ribosome. Decades of experimentation finally led to the structural solution of the prokaryotic ribosome from T. thermophilus [84, 85] and H. marismortui. [86] The natural abundance of the ribosome, its large size, and the inherent stability of the incorporated RNA when complexed with the ribosome allowed sufficient quantities to be purified from these organisms. More recently, the structure of the eukaryotic 80S ribosome was solved following direct harvesting from S. cerevisiae cells [87] as well as the 40S and 60S subunits from T. thermophila. [88, 89] 
Conclusion
Over the past three decades, a new era in RNA biology has been rapidly gaining momentum. What started with the discovery of the first renegade non-coding RNAs and small nuclear RNAs in the 1980s progressed to micro-RNAs in the 2000s and today, with the advancements in deep sequencing, thousands of long non-coding RNAs are being unearthed. Along the way, ribozymes and riboswitches were exposed as remarkable RNAs that utilize their structure to catalyze reactions in a role previously thought to be the sole responsibility of protein enzymes. [90] Overall, RNAs can regulate gene expression at the transcription level, RNA processing and translation, they can protect against foreign nucleic acids, guide DNA synthesis, catalyze reactions, and provide a scaffold for RNP assembly (for a review, see Ref. [91] ). The transcribed non-coding region of human DNA far eclipses the size of the protein-coding region. [91, 92] Additionally, RNA structure and fold variability surpasses that of proteins, in terms of complexity, suggesting a plethora of structurally specific biological functions of which our current understanding barely scratches the surface.
Despite the growing appreciation of the importance of RNAs, the methods used to study them, particularly those used to determine molecular models by high-resolution X-ray diffraction, remain limited. At present, there are 88532 X-ray diffraction structures in the PDB. Only 2.33 % (2062 structures) are of RNA molecules and 1.54 % (1364 structures) are of RNPs, demonstrating the lack of advancement in the area. Unlike the novel techniques, such as cubic-phase lipid crystallization [93] currently being developed for crystallization of membrane proteins, RNA and RNP crystallography so far has lacked a similar step forward. Current techniques, as discussed in the review, are the beginning of tackling the bottleneck surrounding RNA and RNP crystallization. New techniques, utilizing combinations of the methods discussed and novel techniques, are required to further advance the field.
